Absher Wealth Management’s Labcorp LH Stock Holding History

Absher Wealth Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-700	Closed	-$201K	–	82
2025 Q3	$201K	Buy	+700	New	+$188K	0.02%	79

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Absher Wealth Management's LH Position: Q4 2025 in Review

Absher Wealth Management sold out of Labcorp (LH) in Q4 2025, closing a stake of 700 shares — an estimated $201K sold.

Absher Wealth Management first reported a position in LH in Q3 2025 and held it in 1 quarter. The position peaked at $201K in Q3 2025. 1,026 funds tracked by Wall St. Rank hold LH as of Q4 2025.

Absher Wealth Management reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
Absher Wealth Management sold 700 Labcorp shares in Q4 2025, an estimated $201K.
Absher Wealth Management first reported a position in Labcorp in Q3 2025 and held it in 1 quarter.
Absher Wealth Management's Labcorp position peaked at $201K in Q3 2025.
1,026 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Absher Wealth Management's 13F filing for Q4 2025, filed 28 Jan 2026.